| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 895 | 6.718 | 13.065 | 19.966 | 26.468 | 41.469 | 58.730 | 57.683 | 65.132 | 79.413 |
| Total Income - EUR | 895 | 6.718 | 13.065 | 19.966 | 26.468 | 41.515 | 58.811 | 57.750 | 66.923 | 96.151 |
| Total Expenses - EUR | 771 | 4.895 | 4.826 | 11.065 | 9.874 | 17.835 | 15.727 | 11.432 | 21.635 | 23.294 |
| Gross Profit/Loss - EUR | 124 | 1.823 | 8.239 | 8.902 | 16.595 | 23.681 | 43.083 | 46.318 | 45.288 | 72.857 |
| Net Profit/Loss - EUR | 98 | 1.622 | 7.847 | 8.303 | 15.801 | 22.497 | 41.388 | 44.686 | 44.619 | 69.973 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Cardiomed Np Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 225 | 0 | 2.019 | 20.971 | 13.649 | 10.021 | 4.297 | 4.013 | 3.250 | 5.121 |
| Current Assets | 304 | 3.642 | 5.384 | 15.639 | 19.011 | 35.009 | 49.435 | 53.652 | 72.261 | 97.207 |
| Inventories | 24 | 0 | 0 | 0 | 0 | 525 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 156 | 2.235 | 1.473 | 2.221 | 7.385 | 8.722 | 2.219 | 1.456 | 10.716 |
| Cash | 280 | 3.486 | 3.149 | 14.166 | 16.790 | 27.100 | 40.712 | 51.433 | 70.805 | 86.491 |
| Shareholders Funds | 143 | 1.763 | 7.995 | 16.151 | 23.993 | 34.950 | 51.305 | 45.996 | 66.216 | 91.449 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 387 | 1.879 | 2.232 | 20.459 | 8.667 | 10.080 | 3.872 | 13.135 | 10.585 | 12.161 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiomed Np Srl